BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25047009)

  • 21. Negative correlation between the nuclear size and nuclear Lamina component Lamin A in intraductal papillary mucinous neoplasms of the pancreas.
    Hiroe T; Moriya S; Kobayashi S; Nishijima Y; Watanabe A; Shirabe K; Ikota H; Yokoo H; Saio M
    Pathol Oncol Res; 2022; 28():1610684. PubMed ID: 36561231
    [No Abstract]   [Full Text] [Related]  

  • 22. Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas.
    Corcos O; Couvelard A; Dargère D; Sauvanet A; Hammel P; Paradis V; Lévy P; Ruszniewski P; Bedossa P
    Pancreas; 2012 Mar; 41(2):169-74. PubMed ID: 22076567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraductal Papillary Mucinous Neoplasms of the Pancreas: Correlation of Helical Computed Tomography (CT) Features With Pathologic Findings.
    Xu W; Liu X; Zhang J; Yang L
    Acad Radiol; 2017 May; 24(5):609-614. PubMed ID: 28153575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.
    Flanagan MR; Jayaraj A; Xiong W; Yeh MM; Raskind WH; Pillarisetty VG
    World J Gastroenterol; 2015 Mar; 21(9):2820-5. PubMed ID: 25759555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
    Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of MUC4 and MUC5AC is related to the biologic malignancy of intraductal papillary mucinous neoplasms of the pancreas.
    Kanno A; Satoh K; Kimura K; Hirota M; Umino J; Masamune A; Satoh A; Asakura T; Egawa S; Sunamura M; Endoh M; Shimosegawa T
    Pancreas; 2006 Nov; 33(4):391-6. PubMed ID: 17079945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synchronous extrapancreatic malignant papillary mucinous neoplasms in a patient with intraductal papillary mucinous neoplasm of the pancreas: a rare case of simultaneous pancreatic, hepatic, and pulmonary involvement.
    Tarantino I; Mocciaro F; Barresi L; Vitulo P; Liotta R; Curcio G; Granata A; Pisa MD; Traina M
    Pancreas; 2012 Apr; 41(3):501-2. PubMed ID: 22415674
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas.
    Ikemoto T; Sugimoto K; Shimada M; Utsunomiya T; Morine Y; Imura S; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Yamada S
    J Gastroenterol Hepatol; 2015 Jan; 30(1):217-22. PubMed ID: 25041344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of the most severely dysplastic/invasive lesions and mucin phenotypes in intraductal papillary mucinous neoplasm of the pancreas.
    Karasaki H; Mizukami Y; Tokusashi Y; Koizumi K; Ishizaki A; Imai K; Yoshikawa D; Kino S; Sasajima J; Tanno S; Matsumoto K; Miyokawa N; Kono T; Kohgo Y; Furukawa H
    Pancreas; 2011 May; 40(4):588-94. PubMed ID: 21441843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic alterations in adenoma-carcinoma sequencing of intraductal papillary-mucinous neoplasm of the pancreas.
    Nakata B; Yashiro M; Nishioka N; Aya M; Yamada S; Takenaka C; Ohira M; Ishikawa T; Nishino H; Wakasa K; Hirakawa K
    Int J Oncol; 2002 Nov; 21(5):1067-72. PubMed ID: 12370756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
    Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological features of intraductal papillary neoplasms of the bile duct: a comparison with intraductal papillary mucinous neoplasm of the pancreas with reference to subtypes.
    Fukumura Y; Nakanuma Y; Kakuda Y; Takase M; Yao T
    Virchows Arch; 2017 Jul; 471(1):65-76. PubMed ID: 28550497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100P is a novel marker to identify intraductal papillary mucinous neoplasms.
    Nakata K; Nagai E; Ohuchida K; Hayashi A; Miyasaka Y; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
    Hum Pathol; 2010 Jun; 41(6):824-31. PubMed ID: 20153506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smoking Status and the Incidence of Pancreatic Cancer Concomitant With Intraductal Papillary Mucinous Neoplasm.
    Nakagawa T; Masuda A; Toyama H; Shiomi H; Zen Y; Sofue K; Takenaka M; Kobayashi T; Yagi Y; Yamanaka K; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Ku Y; Azuma T
    Pancreas; 2017 Apr; 46(4):582-588. PubMed ID: 28099253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.
    Adsay NV; Conlon KC; Zee SY; Brennan MF; Klimstra DS
    Cancer; 2002 Jan; 94(1):62-77. PubMed ID: 11815961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.